Lynne Powell
Direktor/Vorstandsmitglied bei BIORA THERAPEUTICS, INC.
Vermögen: 3 488 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jeffrey Alter | M | 61 | 5 Jahre | |
| Eric d'Esparbes | M | 56 | 5 Jahre | |
| Clarke Neumann | M | 60 | 10 Jahre | |
| Jill Howe | F | 48 | 3 Jahre | |
| Brian Kotzin | M | 74 | 5 Jahre | |
| Adi Mohanty | M | 57 | 3 Jahre | |
| Jeffrey Allen Ferrell | M | 49 | 10 Jahre | |
| Theresa Heggie | F | 63 | 6 Jahre | |
| Stephen Aselage | M | 73 | 5 Jahre | |
| Paul W. Shabram | M | - | 2 Jahre | |
| John D. Bluth | M | - | 5 Jahre | |
| Sharat Singh | M | - | - | |
| Andrew R. Midler | M | - |
Tavanta Therapeutics, Inc.
 Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | - |
| Stephanie Angelini | F | - | 6 Jahre | |
| Charles Gayer | M | 53 | 9 Jahre | |
| Robyn Hatton | F | - | 11 Jahre | |
| Allison Luo | M | 50 | 7 Jahre | |
| Michael Rhode | M | - | - | |
| Ariella Kelman | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Bennett | M | - | - | |
| Harry Stylli | M | 62 | 11 Jahre | |
| Robert Alexander Ingram | M | 81 | - | |
| Fred Cohen | M | 67 | 6 Jahre | |
| Sanj Patel | M | 54 | 3 Jahre | |
| Andres Brainsky | M | - |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | - |
| Surbhi Sarna | F | 38 | 2 Jahre | |
| Peder Jensen | M | 69 | 4 Jahre | |
| Stanley Erck | M | 76 | 10 Jahre | |
| Samuel R. Nussbaum | M | 75 | 2 Jahre | |
| Emil Chuang | M | 64 | 2 Jahre | |
| Megan Sniecinski | F | 43 | 2 Jahre | |
| Nichole L. Martin | F | 46 | 2 Jahre | |
| Timothy E. Cloutier | M | 50 | 3 Jahre | |
| Hutan Hashemi | M | 45 | 3 Jahre | |
| Troy Seelye | M | 60 | - | |
| Sami Shihabi | M | 53 | 3 Jahre | |
| Anjana Harve | F | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | 10 Jahre |
| Diana Lanchoney | M | 57 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | 7 Jahre |
| Andreas Maetzel | M | 60 | 3 Jahre | |
| Jason Adair | M | - | 4 Jahre | |
| Damon Silvestry | M | 56 | 2 Jahre | |
| Russell Basser | M | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | 21 Jahre |
| Howard Levy | M | 70 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | - |
| Robert Repella | M | 65 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | - |
| Regan Lauer | F | 55 | 2 Jahre | |
| Sean Lavin | M | - | - | |
| Paul Hermecz | M | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | - |
| Gregory Boss | M | 62 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | 8 Jahre |
| Peter J. Turner | M | 74 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | 11 Jahre |
| Brian McNamee | M | 68 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | - |
| Jeannie Joughin | M | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 51 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Lynne Powell
- Persönliches Netzwerk
